Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
|Articles|September 9, 2020
- Balancing Act: Aesthetic Authority Vol.1: No.3
- Volume 1
- Issue 3
My Favorite Device
Devices are a huge investment and deciding to bring one into your practice is significant. Three Aesthetic Authority EAB members share their favorites.
Advertisement
We asked our Editorial Advisory Board for their input on lasers for this issue: What’s your favorite energy device and why?
The emphasis is on favorite, which can be justified in any way that makes it so: best value, biggest workhorse, best customer service, most profitable, best results, offers novel solutions. This is what they told us.
Articles in this issue
almost 6 years ago
Unlock Your Profit Potential with the Revolutionary PRX Protocolalmost 6 years ago
Strategies for A Successful Hair Practicealmost 6 years ago
Starting a Hair Practicealmost 6 years ago
Balancing Act: Aesthetic Authority Vol.1: No.3about 6 years ago
Strength and Success in Our Specialtyabout 6 years ago
Patient Maskne Prevention Tipsabout 6 years ago
Maskne Treatment Protocolabout 6 years ago
Treating Maskne Inside and Outabout 6 years ago
Examining CBD Skin Benefitsabout 6 years ago
A Closer Look at CBDAdvertisement
Related to this article
Advertisement
Advertisement
Trending on Dermatology Times
1
Galderma to Acquire ZO Skin Health for $1.5 Billion
2
Alopecia Areata Is a Medical Disease: Treatment Options and Defining Severity
3
First-in-Class Oral PKM2 Modulator Shows Early Efficacy in Atopic Dermatitis
4
Exosome Progress and Remibrutinib Label Expansion
5